Selected research
Industry Growth & Trends
Global Armodafinil Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Armodafinil market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Armodafinil is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Armodafinil is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Armodafinil is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Armodafinil market include Apotex, Aurobindo, Lupin, Natco Pharma, Mylan, Sandoz and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Armodafinil market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Armodafinil market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Armodafinil market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Armodafinil.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Armodafinil market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Armodafinil Market by Company
Apotex
Aurobindo
Lupin
Natco Pharma
Mylan
Sandoz
Teva
Armodafinil Segment by Type
50 mg Tablets
250 mg Tablets
200 mg Tablets
150 mg Tablets
Armodafinil Segment by Application
Obstructive Sleep Apnea (OSA) and Narcolepsy
Patients with Severe Hepatic Impairment
Shift Work Disorder (SWD)
Geriatric Patients
Armodafinil Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Armodafinil market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Armodafinil and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Armodafinil.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Armodafinil companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 50 mg Tablets
- 250 mg Tablets
- 200 mg Tablets
- 150 mg Tablets
Applications
- Obstructive Sleep Apnea (OSA) and Narcolepsy
- Patients with Severe Hepatic Impairment
- Shift Work Disorder (SWD)
- Geriatric Patients
Companies covered
- Apotex
- Aurobindo
- Lupin
- Natco Pharma
- Mylan
- Sandoz
- Teva
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Armodafinil Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Armodafinil Market Size by Region (2021-2032)
- 1.4.1 Global Armodafinil Market Size by Region (2021-2026)
- 1.4.2 Global Armodafinil Market Size by Region (2027-2032)
- 1.5 Key Regions Armodafinil Market Size (2021-2032)
- 1.5.1 North America Armodafinil Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Armodafinil Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Armodafinil Market Size Growth Rate (2021-2032)
- 1.5.4 South America Armodafinil Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Armodafinil Market Size Growth Rate (2021-2032)
2 Armodafinil Market by Type
- 2.1 Type Introduction
- 2.1.1 50 mg Tablets
- 2.1.2 250 mg Tablets
- 2.1.3 200 mg Tablets
- 2.1.4 150 mg Tablets
- 2.2 Global Armodafinil Market Size by Type
- 2.2.1 Global Armodafinil Market Size Overview by Type (2021-2032)
- 2.2.2 Global Armodafinil Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Armodafinil Market Size Forecasted by Type (2027-2032)
- 2.3 Global Armodafinil Market Size by Regions
- 2.3.1 North America Armodafinil Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Armodafinil Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Armodafinil Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Armodafinil Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Armodafinil Market Size Breakdown by Type (2021-2026)
3 Armodafinil Market by Application
- 3.1 Type Introduction
- 3.1.1 Obstructive Sleep Apnea (OSA) and Narcolepsy
- 3.1.2 Patients with Severe Hepatic Impairment
- 3.1.3 Shift Work Disorder (SWD)
- 3.1.4 Geriatric Patients
- 3.2 Global Armodafinil Market Size by Application
- 3.2.1 Global Armodafinil Market Size Overview by Application (2021-2032)
- 3.2.2 Global Armodafinil Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Armodafinil Market Size Forecasted by Application (2027-2032)
- 3.3 Global Armodafinil Market Size by Regions
- 3.3.1 North America Armodafinil Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Armodafinil Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Armodafinil Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Armodafinil Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Armodafinil Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Armodafinil Industry Trends
- 4.2 Armodafinil Industry Drivers
- 4.3 Armodafinil Industry Opportunities and Challenges
- 4.4 Armodafinil Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Armodafinil Revenue (2021-2026)
- 5.2 Global Armodafinil Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Armodafinil Key Company Headquarters & Area Served
- 5.4 Global Armodafinil Company, Product Type & Application
- 5.5 Global Armodafinil Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Armodafinil Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Armodafinil Players Market Share by Revenue in 2025
- 5.6.3 2025 Armodafinil Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Apotex
- 6.1.1 Apotex Company Information
- 6.1.2 Apotex Business Overview
- 6.1.3 Apotex Armodafinil Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Apotex Armodafinil Product Portfolio
- 6.1.5 Apotex Recent Developments
- 6.2 Aurobindo
- 6.2.1 Aurobindo Company Information
- 6.2.2 Aurobindo Business Overview
- 6.2.3 Aurobindo Armodafinil Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Aurobindo Armodafinil Product Portfolio
- 6.2.5 Aurobindo Recent Developments
- 6.3 Lupin
- 6.3.1 Lupin Company Information
- 6.3.2 Lupin Business Overview
- 6.3.3 Lupin Armodafinil Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Lupin Armodafinil Product Portfolio
- 6.3.5 Lupin Recent Developments
- 6.4 Natco Pharma
- 6.4.1 Natco Pharma Company Information
- 6.4.2 Natco Pharma Business Overview
- 6.4.3 Natco Pharma Armodafinil Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Natco Pharma Armodafinil Product Portfolio
- 6.4.5 Natco Pharma Recent Developments
- 6.5 Mylan
- 6.5.1 Mylan Company Information
- 6.5.2 Mylan Business Overview
- 6.5.3 Mylan Armodafinil Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Mylan Armodafinil Product Portfolio
- 6.5.5 Mylan Recent Developments
- 6.6 Sandoz
- 6.6.1 Sandoz Company Information
- 6.6.2 Sandoz Business Overview
- 6.6.3 Sandoz Armodafinil Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Sandoz Armodafinil Product Portfolio
- 6.6.5 Sandoz Recent Developments
- 6.7 Teva
- 6.7.1 Teva Company Information
- 6.7.2 Teva Business Overview
- 6.7.3 Teva Armodafinil Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Teva Armodafinil Product Portfolio
- 6.7.5 Teva Recent Developments
7 North America
- 7.1 North America Armodafinil Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Armodafinil Market Size by Country (2021-2026)
- 7.3 North America Armodafinil Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Armodafinil Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Armodafinil Market Size by Country (2021-2026)
- 8.3 Europe Armodafinil Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Armodafinil Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Armodafinil Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Armodafinil Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Armodafinil Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Armodafinil Market Size by Country (2021-2026)
- 10.3 South America Armodafinil Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Armodafinil Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Armodafinil Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Armodafinil Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst